Resources
March 28, 2018 – 2 PM ET What if you could use predictive models like biomarkers to pre-emptively screen and more effectively target patients who are more likely to respond to your drug in trials and in practice? What if you could rapidly answer questions on comparative treatment outcomes and predict those most likely to[…]
February 28, 2018 – 2:00 pm – 3:00 pm ET Join Dr. Richard Gliklich, CEO of OM1, to explore the opportunities with using big data, predictive analytics and measurable outcomes to develop and implement outcomes based programs that align stakeholder incentives around benefits and costs. Discussion will include: Using standardized outcomes measurement Predicting treatment benefit,[…]
Built In Boston’s 50 Startups to Watch in 2018 Published on Built In Boston January 16, 2018 Boston’s tech sector continued to blossom in 2017, as startups launched in virtually every industry — from cybersecurity to robotics and everything in between. Meanwhile, venture capital firms continued to pour money into the city’s legacy industries, including[…]
Published on HealthEconomics.com on January 3, 2018 As artificial intelligence (AI) and Big Data are lauded for their potential uses in life sciences and healthcare, it is becoming difficult to differentiate between the myriad of terms and technologies and their real value in advancing real-world evidence (RWE). In this article, we explore key AI[…]
January 30, 2018 – 11 am – 12 pm ET – Register Fibrotic diseases, such as non-alcoholic steatohepatitis (NASH), are responsible for 45% of US deaths a year. With a growing occurrence and few treatment options, more research is needed to better understand natural history and progression of these diseases, treatments and outcomes. This session[…]
